0NQH Stock Overview
Offers in-patient, semi-patient, and outpatient healthcare services in Germany. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 0NQH from our risk checks.
RHÖN-KLINIKUM Aktiengesellschaft Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €12.60 |
| 52 Week High | €13.10 |
| 52 Week Low | €9.75 |
| Beta | -0.11 |
| 11 Month Change | -0.79% |
| 3 Month Change | 9.09% |
| 1 Year Change | 14.03% |
| 33 Year Change | -19.64% |
| 5 Year Change | -31.60% |
| Change since IPO | -36.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0NQH | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 0% | -1.3% | 0.7% |
| 1Y | 14.0% | -23.6% | 6.1% |
Return vs Industry: 0NQH exceeded the UK Healthcare industry which returned -23.6% over the past year.
Return vs Market: 0NQH exceeded the UK Market which returned 6.1% over the past year.
Price Volatility
| 0NQH volatility | |
|---|---|
| 0NQH Average Weekly Movement | 4.2% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0NQH has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0NQH's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 18,507 | Tobias Kaltenbach | www.rhoen-klinikum-ag.com |
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. It also operates acute hospitals, medical care centers, and rehabilitation hospitals. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.
RHÖN-KLINIKUM Aktiengesellschaft Fundamentals Summary
| 0NQH fundamental statistics | |
|---|---|
| Market cap | €850.12m |
| Earnings (TTM) | €44.87m |
| Revenue (TTM) | €1.84b |
18.9x
P/E Ratio0.5x
P/S RatioIs 0NQH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0NQH income statement (TTM) | |
|---|---|
| Revenue | €1.84b |
| Cost of Revenue | €1.62b |
| Gross Profit | €211.75m |
| Other Expenses | €166.88m |
| Earnings | €44.87m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 27, 2025
| Earnings per share (EPS) | 0.67 |
| Gross Margin | 11.54% |
| Net Profit Margin | 2.44% |
| Debt/Equity Ratio | 10.9% |
How did 0NQH perform over the long term?
See historical performance and comparison